Study of risk factors for jaw bone damage from certain drugs
Part of Bones, joints & muscles, Mouth & dental clinical trials.
This study looks at people who have jaw bone damage (osteonecrosis) caused by medications. Researchers want to understand what treatments and risk factors are linked to this condition to help improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are a man or woman
- You have jaw bone damage caused by medication (MRONJ)
- You or your legal representative can agree to join the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people taking bone-strengthening drugs (like bisphosphonates or denosumab) who need dental work, such as tooth extraction or root canals. It aims to reduce the rare risk of jaw bone damage (osteonecrosis of the jaw) and help dentists and doctors choose the best timing for procedures.
This study looks at how a specific jaw problem (osteonecrosis) may happen in people taking bone-strengthening medications. It aims to better understand and manage this side effect.
This study looks at what changes happen in the jawbone in people with osteonecrosis of the jaw (a damaged jawbone area), whether or not they take certain cancer/bone medicines. It may help doctors better understand the condition and how it behaves over time.
This study looks at how bone quality changes over time in patients with medication-related osteonecrosis of the jaw (MRONJ), a condition where jaw bone fails to heal after certain medications. By comparing repeated CT scans, researchers hope to better understand the condition and improve care.
This study compares two ways to treat a jaw bone problem caused by medications (called MRONJ) when it happens around a dental implant. One option is to keep the implant and treat the bone, the other is to remove the implant. The goal is to see which approach leads to better healing.
This trial tests a combination of medicines (pentoxifylline and tocopherol, a form of vitamin E) to treat damage to the jaw bone caused by bone-strengthening drugs. If you have Stage 2 MRONJ and meet other criteria, this treatment may help heal the bone.
Hear when a new Medication-Related Osteonecrosis of Jaw trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.